2/6/09 update
Optimism that a stimulus plan would soon be approved provided investors with a stimulus to buy stocks, getting February off to a nice start. At Friday's close, the Nasdaq Composite Index was up 1.28% CYTD, or "Contest Year To Date" (vs. down -6.06% CYTD a week ago). The Nasdaq Biotech Index had a good week as well, closing up 7.75% CYTD (vs. up 2.06% CYTD a week ago). And the Contest median followed the trend, closing up 8.02% CYTD (vs. up .58% CYTD a week ago).
Three portfolios were running neck and neck in the battle for first place: ENZYME up 26.48% CYTD, GHMM up 26.12% CYTD and SCARAM up 25.33% CYTD.
At Friday's close, 26 of the 32 Contest portfolios were in the black and 16 of the 32 beat the NBI.
Have a terrific weekend folks!
Below is the Top Ten list on 2/6/09:
2/6/09
Rank Name Profit/Loss
1 ENZYME 26,478
2 GHMM 26,115
3 SCARAM 25,326
4 BULBA 18,228
5 ASHLEY 12,837
6 ROCKY 12,365
7 GEORGIA 12,124
8 RKRW 11,749
9 CASA 11,510
10 ROBERT 11,256
(All corrections, especially adjustments for splits, greatly appreciated.) |
